Cannabidiol as a novel candidate alcohol use disorder pharmacotherapy: a systematic review
There is substantial interest in the therapeutic potential of cannabidiol (CBD), a
nonpsychoactive cannabinoid found in plants of the genus Cannabis. The goal of the current …
nonpsychoactive cannabinoid found in plants of the genus Cannabis. The goal of the current …
Therapeutic prospects of cannabidiol for alcohol use disorder and alcohol-related damages on the liver and the brain
J De Ternay, M Naassila, M Nourredine… - Frontiers in …, 2019 - frontiersin.org
Background: Cannabidiol (CBD) is a natural component of cannabis that possesses a
widespread and complex immunomodulatory, antioxidant, anxiolytic, and antiepileptic …
widespread and complex immunomodulatory, antioxidant, anxiolytic, and antiepileptic …
Cannabidiol in the context of substance use disorder treatment: A systematic review
V Paulus, J Billieux, A Benyamina, L Karila - Addictive behaviors, 2022 - Elsevier
Introduction Cannabidiol (CBD) is a phytocannabinoid found in the Cannabis plant. CBD
has received significant medical attention in relation to its anticonvulsant, anxiolytic, and …
has received significant medical attention in relation to its anticonvulsant, anxiolytic, and …
Cannabidiol as an intervention for addictive behaviors: a systematic review of the evidence
M Prud'homme, R Cata… - … abuse: research and …, 2015 - journals.sagepub.com
Drug addiction is a chronically relapsing disorder characterized by the compulsive desire to
use drugs and a loss of control over consumption. Cannabidiol (CBD), the second most …
use drugs and a loss of control over consumption. Cannabidiol (CBD), the second most …
Effects of cannabidiol on alcohol-related outcomes: A review of preclinical and human research.
CN Nona, CS Hendershot, B Le Foll - Experimental and Clinical …, 2019 - psycnet.apa.org
Increased access to medicinal and recreational cannabis will be accompanied by greater
exposure to its chemical constituents, including Δ 9-tetrahydrocannabinol (Δ 9-THC) and …
exposure to its chemical constituents, including Δ 9-tetrahydrocannabinol (Δ 9-THC) and …
Cannabidiol and substance use disorder: Dream or reality
S Karimi-Haghighi, Y Razavi, D Iezzi, AF Scheyer… - …, 2022 - Elsevier
Background Cannabidiol (CBD) is one of the major constituents of Cannabis sativa L. that
lacks psychotomimetic and rewarding properties and inhibits the rewarding and reinforcing …
lacks psychotomimetic and rewarding properties and inhibits the rewarding and reinforcing …
Cannabidiol: pharmacology and therapeutic targets
SC Britch, S Babalonis, SL Walsh - Psychopharmacology, 2021 - Springer
Rationale Cannabidiol (CBD) products lacking regulatory approval are being used to self-
treat a myriad of conditions and for their unsubstantiated health benefits. The scientific …
treat a myriad of conditions and for their unsubstantiated health benefits. The scientific …
Therapeutic efficacy of cannabidiol (CBD): a review of the evidence from clinical trials and human laboratory studies
DJ Sholler, L Schoene, TR Spindle - Current addiction reports, 2020 - Springer
Rigorous, controlled evidence for the therapeutic efficacy of CBD is lacking for many health
conditions. Possible concerns with the use of CBD as a therapeutic include the potential for …
conditions. Possible concerns with the use of CBD as a therapeutic include the potential for …
Current status and prospects for cannabidiol preparations as new therapeutic agents
PS Fasinu, S Phillips, MA ElSohly… - … : The Journal of Human …, 2016 - Wiley Online Library
States and the federal government are under growing pressure to legalize the use of
cannabis products for medical purposes in the United States. Sixteen states have legalized …
cannabis products for medical purposes in the United States. Sixteen states have legalized …
Cannabidiol reduces ethanol consumption, motivation and relapse in mice
A Viudez‐Martínez, MS García‐Gutiérrez… - Addiction …, 2018 - Wiley Online Library
This study evaluated the effects of cannabidiol (CBD) on ethanol reinforcement, motivation
and relapse in C57BL/6 J mice. The effects of CBD (60 mg/kg, ip) on blood ethanol …
and relapse in C57BL/6 J mice. The effects of CBD (60 mg/kg, ip) on blood ethanol …